These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 3963089)

  • 21. Changed indications for Parlodel (bromocriptine) for lactation suppression.
    Morgans D
    Med J Aust; 1995 Aug; 163(3):164. PubMed ID: 7643776
    [No Abstract]   [Full Text] [Related]  

  • 22. Suppression of lactation comparing stilboestrol and bromocriptine (CB154).
    Ladipo OA; Ojo OA
    Niger Med J; 1979 Jan; 9(1):77-9. PubMed ID: 463344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Puerperal hypertension, stroke, and seizures after suppression of lactation with bromocriptine.
    Katz M; Kroll D; Pak I; Osimoni A; Hirsch M
    Obstet Gynecol; 1985 Dec; 66(6):822-4. PubMed ID: 3840873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled trial of bromocriptine, quinoestrol, and placebo in suppression of puerperal lactation.
    Walker S; Groom G; Davis RH; Hibbard BM; Griffiths K
    Lancet; 1975 Nov; 2(7940):842-4. PubMed ID: 53330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metergoline in the inhibition of puerperal lactation.
    Delitala G; Masala A; Alagna S; Devilla L; Lotti G
    Br Med J; 1977 Mar; 1(6063):744-6. PubMed ID: 322792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bromocriptine mesylate for prevention of postpartum lactation.
    Duchesne C; Leke R
    Obstet Gynecol; 1981 Apr; 57(4):464-7. PubMed ID: 7243095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe cardiac dysrhythmia in patients using bromocriptine postpartum.
    Iffy L; O'Donnell J; Correia J; Hopp L
    Am J Ther; 1998 Mar; 5(2):111-5. PubMed ID: 10099047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative effects of buccal Syntocinon and an ergot alkaloid in the postpartum period].
    Monnier A
    Schweiz Med Wochenschr; 1966 Apr; 96(14):468-71. PubMed ID: 6010606
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison of 2 bromo alpha ergocryptine, quinoestrol and placebo in suppression of puerperal lactation [proceedings].
    Walker S
    Br J Clin Pharmacol; 1975 Aug; 2(4):368P-369P. PubMed ID: 788734
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of hypertension in bromocriptine-related puerperal intracranial hemorrhage.
    Kirsch C; Iffy L; Zito GE; McArdle JJ
    Neuroradiology; 2001 Apr; 43(4):302-4. PubMed ID: 11338413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bromocriptine in an injectable retard form for puerperal lactation suppression: comparison with Estandron prolongatum.
    Defoort P; Thiery M; Baele G; Clement D; Dhont M
    Obstet Gynecol; 1987 Dec; 70(6):866-9. PubMed ID: 3684122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of lactation by an antiestrogen, tamoxifen.
    Shaaban MM
    Eur J Obstet Gynecol Reprod Biol; 1975; 4(5):167-9. PubMed ID: 1053489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention and suppression of post-partum lactation with 2-bromo-alpha-ergocryptine (CB-154).
    Macleod SC; Scott J; Lord L; Brodie G; Perlin I; Simpson AA
    Clin Endocrinol (Oxf); 1977; 6 Suppl():65S-70S. PubMed ID: 617072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Parlodel in the treatment of lactation mastitis].
    Myshkin KI; Raskin MA; Cherkasova VA
    Akush Ginekol (Mosk); 1988 Sep; (9):53-4. PubMed ID: 3232735
    [No Abstract]   [Full Text] [Related]  

  • 35. Factors influencing puerperal thrombo-embolism.
    Tindall VR
    J Obstet Gynaecol Br Commonw; 1968 Dec; 75(12):1324-7. PubMed ID: 5702373
    [No Abstract]   [Full Text] [Related]  

  • 36. [Usefulness of estradiol and parlodel in puerperal lactation inhibition].
    Myśkow M; Zalewski J
    Wiad Lek; 1980 Mar; 33(5):351-3. PubMed ID: 7376671
    [No Abstract]   [Full Text] [Related]  

  • 37. Postpartum psychosis induced by bromocriptine.
    Canterbury RJ; Haskins B; Kahn N; Saathoff G; Yazel JJ
    South Med J; 1987 Nov; 80(11):1463-4. PubMed ID: 3686155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cabergoline versus bromocriptine in suppression of lactation after cesarean delivery.
    Giorda G; de Vincentiis S; Motta T; Casazza S; Fadin M; D'Alberton A
    Gynecol Obstet Invest; 1991; 31(2):93-6. PubMed ID: 2037265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Puerperal thromboembolism in relation to the inhibition of lactation by oestrogen therapy.
    Jeffcoate TN; Miller J; Roos RF; Tindall VR
    Br Med J; 1968 Oct; 4(5622):19-25. PubMed ID: 5677208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of lactation. A comparison of bromocriptine and prostaglandin E2.
    England MJ; Tjallinks A; Hofmeyr J; Harber J
    J Reprod Med; 1988 Jul; 33(7):630-2. PubMed ID: 3172062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.